119 related articles for article (PubMed ID: 1321101)
1. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding.
Moerlein SM; Banks WR; Parkinson D
Int J Rad Appl Instrum A; 1992 Jul; 43(7):913-7. PubMed ID: 1321101
[TBL] [Abstract][Full Text] [Related]
2. In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.
Suehiro M; Dannals RF; Scheffel U; Stathis M; Wilson AA; Ravert HT; Villemagne VL; Sanchez-Roa PM; Wagner HN
J Nucl Med; 1990 Dec; 31(12):2015-21. PubMed ID: 2148346
[TBL] [Abstract][Full Text] [Related]
3. In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding.
Moerlein SM; Perlmutter JS; Markham J; Welch MJ
J Cereb Blood Flow Metab; 1997 Aug; 17(8):833-45. PubMed ID: 9290581
[TBL] [Abstract][Full Text] [Related]
4. Specific binding of 3N-(2'-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET.
Moerlein SM; Perlmutter JS
Neurosci Lett; 1992 Dec; 148(1-2):97-100. PubMed ID: 1300511
[TBL] [Abstract][Full Text] [Related]
5. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand.
Moerlein SM; Perlmutter JS; Welch MJ
Nucl Med Biol; 1995 Aug; 22(6):809-15. PubMed ID: 8535343
[TBL] [Abstract][Full Text] [Related]
6. Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates.
Moerlein SM; Perlmutter JS; Cutler PD; Welch MJ
Nucl Med Biol; 1997 May; 24(4):311-8. PubMed ID: 9257329
[TBL] [Abstract][Full Text] [Related]
7. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
[TBL] [Abstract][Full Text] [Related]
8. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals.
Nikolaus S; Larisch R; Beu M; Hamacher K; Forutan F; Vosberg H; Müller HW
J Nucl Med; 2003 Apr; 44(4):618-24. PubMed ID: 12679408
[TBL] [Abstract][Full Text] [Related]
9. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.
Eisenstein SA; Koller JM; Piccirillo M; Kim A; Antenor-Dorsey JA; Videen TO; Snyder AZ; Karimi M; Moerlein SM; Black KJ; Perlmutter JS; Hershey T
Synapse; 2012 Sep; 66(9):770-80. PubMed ID: 22535514
[TBL] [Abstract][Full Text] [Related]
10. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.
Antenor-Dorsey JA; Markham J; Moerlein SM; Videen TO; Perlmutter JS
Nucl Med Biol; 2008 Apr; 35(3):335-41. PubMed ID: 18355689
[TBL] [Abstract][Full Text] [Related]
11. A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding.
Halldin C; Farde L; Högberg T; Hall H; Ström P; Ohlberger A; Solin O
Int J Rad Appl Instrum B; 1991; 18(8):871-81. PubMed ID: 1839303
[TBL] [Abstract][Full Text] [Related]
12. Radiochemical synthesis of [18F]fluororaclopride.
Kiesewetter DO; Brücke T; Finn RD
Int J Rad Appl Instrum A; 1989; 40(6):455-60. PubMed ID: 2551844
[TBL] [Abstract][Full Text] [Related]
13. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
[TBL] [Abstract][Full Text] [Related]
14. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors.
Yang ZY; Perry B; Mukherjee J
Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 75Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography.
Moerlein SM; Laufer P; Stöcklin G; Pawlik G; Wienhard K; Heiss WD
Eur J Nucl Med; 1986; 12(4):211-6. PubMed ID: 2876896
[TBL] [Abstract][Full Text] [Related]
16. No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography.
Satyamurthy N; Bida GT; Barrio JR; Luxen A; Mazziotta JC; Huang SC; Phelps ME
Int J Rad Appl Instrum B; 1986; 13(6):617-24. PubMed ID: 3494003
[TBL] [Abstract][Full Text] [Related]
17. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.
Logan J; Wolf AP; Shiue CY; Fowler JS
J Neurochem; 1987 Jan; 48(1):73-83. PubMed ID: 2432176
[TBL] [Abstract][Full Text] [Related]
18. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain.
Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD
Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.
Arnett CD; Shiue CY; Wolf AP; Fowler JS; Logan J; Watanabe M
J Neurochem; 1985 Mar; 44(3):835-44. PubMed ID: 2579198
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography.
Halldin C; Högberg T; Farde L
Nucl Med Biol; 1994 May; 21(4):627-31. PubMed ID: 9234320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
